A Cure for Cancer…Hidden in Plain Sight
Dr. David Williams
August 2019
fenbendazole (Panacur C made by Merck Animal Health)
https://fenbendazole.s3.amazonaws.com/A-Cure-for-Cancer-Hidden-in-Plain-Sight-July-2019-Dr-David-Williams.pdf
Good info! TY
Most welQome!
Excellent stuff here and i will remember it:
heres a clip”:
...........................
The scientist happened to be
testing the effects of their existing
products on mice that had various
cancers. That’s when she discovered
that one of their dog products
(a dewormer) was 100 percent
effective. This same scientist had
stage 4 brain cancer and, like Joe,
was also given three months to
live. She started taking the dog
dewormer and six weeks later, she
was clear of the cancer.
On January 15, 2017, without
informing the oncologists at MD
Anderson, Joe started taking the
same dewormer while continuing on
the experimental drug.
Every quarter since he began this
treatment, Joe goes to MD Anderson
for a PET scan. May 2017 was three
months after having the PET scan
that lit up like a Christmas tree,
with cancer from “head to tail.” The
May scan came back all clear. There
was no sign of residual tumors, no
recurrent tumors, and no signs of
metastasis.
The oncologists were totally
mystified. Joe suspected it was the
dewormer but decided that it wasn’t
the right time to tell them.
At that point he couldn’t be 100
percent certain whether it was the
dewormer working or the clinical
trial drug they were giving him.
He certainly didn’t want them to
take him off the trial drug if it was
responsible for clearing the tumors.
The clinical trial ended in
September 2017, and he was
scheduled for another PET scan.
That scan was also all clear, without
any sign of cancer.
Since the clinical trial had ended
and getting kicked off was no longer
a concern, he decided it was time to
come clean and tell the oncologists
about using the dewormer. But
before telling them, he wanted to
know how many people were in the
same clinical trial as he was, and
how many of them had responded
positively to the experimental drug.
He was told 1,100 patients were in
the same trial and taking the exact
same medication as Joe. However,
Joe was the only person whose
cancer had gone into remission.
It obviously wasn’t a result of the
experimental drug.
That’s when Joe told them about
taking the dewormer. They were
shocked. But their reply was even
more shocking.
Here is their conversation with
Joe, as he relayed it to me:
“We’ve known for decades that
the anthelmintic class of drugs
could have possible efficacy against
cancer. In fact in the 1980s and
1990s there was an anthelmintic
drug called Levamisole that was
used on colon cancer.”
Joe said, “Doc, if you have known
for decades, why hasn’t more
research been done on it?”
He replied, “Probably because of
money. All of these drugs are far off
patent and nobody is going to spend
a gazillion dollars to repurpose them
for cancer, only to have generic
competition the next day.”
The “Business” of
Cancer In America
Personally, I understand this
situation. I’ve seen similar scenarios
repeated over and over again in
health care.
What I don’t understand, however,
is why the public is always kept in
the dark about potentially lifesaving
Please be advised that the veterinary 'fenbendazole' has been reformulated as Mebendazol, easier for human consumption.
Several studies show mebendazole exhibits potent antitumor properties. mebendazole significantly inhibited cancer cell growth, migration, and metastatic formation of adrenocortical carcinoma, both in vitro and in vivo. Treatment of lung cancer cell lines with mebendazole caused mitotic arrest, followed by apoptotic cell death with the feature of caspase activation and cytochrome c release. Mebendazole induced a dose- and time-dependent apoptotic response in human lung cancer cell lines, and apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. The anti-cancer effect of mebendazole comes from preclinical studies and case reports.
and
Ivermectin from valleyvet.com